An exciting future for microbial molecular biology and physiology
mBio · 13.08.2025 · 16 (8)
DOI: 10.1128/mbio.00694-25 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift mBio, erschienen am 13.08.2025. Verfasst von Andrew A Bridges und 11 weiteren Autor:innen. Beteiligte Einrichtung: Biological Sciences, Carnegie Mellon University, Pittsburgh, Pennsylvania, USA. Hauptthemen laut MEDLINE: Molecular Biology, Microbiology, Bacteria, Bacterial Physiological Phenomena. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 170 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NIAID NIH HHS, NIH HHS.
Abstract (Originalsprache)
Continuous advances in technologies ranging from deep sequencing and genetic manipulation to mass spectrometry, single cell imaging, and structural biology have led to previously unimaginable advances in our understanding of microbial physiology and the molecular mechanisms underlying microbial responses in a multitude of environments. Simultaneously, these advances are revealing how much more there is to learn. At the 2024 virtual retreat of the Molecular Biology and Physiology (MBP) Community of the Council on Microbial Sciences (COMS) of the American Society for Microbiology (ASM), eight early-career investigators, along with retreat attendees, discussed some of these astounding advances, as well as the challenges and opportunities the developments raise. Motivated by these discussions, we review the state-of-the-art in molecular microbiology and provide an outlook on this field. Our hope is that the topics discussed here can serve as an inspiration for the development of future technologies, resources, and guidelines and for the training of the next generation of microbiologists.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Biological Sciences, Carnegie Mellon University, Pittsburgh, Pennsylvania, USA.
- Department of Bioengineering, University of California, Berkeley, California, USA.
- Department of Pathology, Microbiology and Immunology, College of Medicine, University of Nebraska, Omaha, Nebraska, USA.
- Department of Structural Biology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
- Department of Microbiology, University of Washington, Seattle, Washington, USA.
- Department of Microbiology and Molecular Genetics, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas, USA.
ORCID-Profile: Andrew A Bridges, Leah Guthrie, McKenzie Lehman, Elizabeth H Kellogg, Samantha Wellington Miranda, Andrew Pountain, Anthony L Shiver, Andrew Varble, Elizabeth A Shank, Gisela Storz
Förderung
- NIGMS NIH HHS
- NIAID NIH HHS
- NIH HHS
- Intramural NIH HHS
- Charles E. Kaufman Foundation
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- National Institutes of Health
Zitieren
APA
Bridges, A. A., Guthrie, L., Lehman, M., Kellogg, E. H., Miranda, S. W., Pountain, A., Shiver, A. L., Varble, A., Molecular Biology and Physiology Community of the Council on Microbial Sciences, Kaplan, H. B., Shank, E. A., & Storz, G. (2025). An exciting future for microbial molecular biology and physiology. mBio, 16(8). https://doi.org/10.1128/mbio.00694-25
Vancouver
Bridges AA, Guthrie L, Lehman M, Kellogg EH, Miranda SW, Pountain A, et al. An exciting future for microbial molecular biology and physiology. mBio. 2025;16(8). doi:10.1128/mbio.00694-25
BibTeX
@article{Bridges2025,
author = {Bridges, Andrew A and Guthrie, Leah and Lehman, McKenzie and Kellogg, Elizabeth H and Miranda, Samantha Wellington and Pountain, Andrew and Shiver, Anthony L and Varble, Andrew and Molecular Biology and Physiology Community of the Council on Microbial Sciences, Molecular Biology and Physiology Community of the Council on Microbial Sciences and Kaplan, Heidi B and Shank, Elizabeth A and Storz, Gisela},
title = {An exciting future for microbial molecular biology and physiology},
journal = {mBio},
year = {2025},
volume = {16},
number = {8},
doi = {10.1128/mbio.00694-25}
}
EUVIMED